N-terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 2, 2012, Pages

  D'Errico, Maria P ^a   Grimaldi, Luca ^a   Petruzzelli, Maria F ^a   Gianicolo, Emilio A L ^b   Tramacere, Francesco ^a   Monetti, Antonio ^a   Placella, Roberto ^a   Pili, Giorgio ^a   Andreassi, Maria Grazia ^b   Sicari, Rosa ^b   Picano, Eugenio ^b   Portaluri, Maurizio ^a,b  

^a A Perrino Hospital   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Brain natriuretic peptide; Breast cancer; Dosimetric constraints; Radiotherapy; Troponin

Indexed keywords

ADJUVANT RADIOTHERAPY; BRAIN NATRIURETIC PEPTIDE; BREAST CANCER; BREAST CONSERVING SURGERY; CARDIAC BIOMARKERS; CARDIOVASCULAR MORTALITY; CONTROL GROUPS; DOSIMETRIC CONSTRAINTS; GEOMETRIC PARAMETER; HIGH DOSE; HIGH DOSE LEVELS; LEFT VENTRICLES; MEAN DOSE; N-TERMINALS; NATRIURETIC PEPTIDES; PLASMA CONCENTRATION; PLASMA LEVELS; TROPONIN; UPPER LIMITS;

BIOMARKERS; CARDIOVASCULAR SURGERY; DISEASES; DOSIMETERS; DOSIMETRY; ECHOCARDIOGRAPHY; HEART; PEPTIDES; PLASMAS;

RADIOTHERAPY;

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTHRACYCLINE; BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAXANE DERIVATIVE; TROPONIN I;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL EVALUATION; CONTROLLED STUDY; HEART INJURY; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIATION DOSE; RADIATION INJURY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANTHRACYCLINES; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART VENTRICLES; HUMANS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; ORGANS AT RISK; PEPTIDE FRAGMENTS; RADIATION DOSAGE; RADIATION INJURIES; TOMOGRAPHY, X-RAY COMPUTED; TROPONIN I;

EID: 84855859410     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.03.058     Document Type: Article

References (30)

1. Early Breast Cancer Trialist Collaborative Group Effects of radiotherapy and surgery in early breast cancer: An overview of the randomized trials N Engl J Med 333 1995 1444-1155
2. Early Breast Cancer Trialist Collaborative Group Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomized trials Lancet 355 2000 1757 1770
3. E. Senkus-Konefka, and J. Jassem Cardiovascular effects of breast cancer radiotherapy Cancer Treat Rev 33 2007 578 593
4. S.C. Darby, P. McGale, and C.W. Taylor Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300, 000 women in US SEER cancer registries Lancet Oncol 6 2005 557 565
5. C.W. Taylor, P. McGale, and S.C. Darby Cardiac risks of breast-cancer radiotherapy: A contemporary view Clin Oncol (R Coll Radiol) 18 2006 236 246
6. R. Roychoudhuri, D. Robinson, and V. Putcha Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: A population-based study BMC Cancer 7 2007 9
7. C.W. Taylor, J.M. Povall, and P. McGale Cardiac dose from tangential breast cancer radiotherapy in the year 2006 Int J Radiat Oncol Biol Phys 72 2008 501 507
8. B. Seddon, A. Cook, and L. Gothard Detection of defects in myocardial perfusion imaging in patients with early breast cancer treated with radiotherapy Radiother Oncol 64 2002 53 63
9. L.B. Marks, X. Yu, and R.G. Prosnitz The incidence and functional consequences of RT-associated cardiac perfusion defects Int J Radiat Oncol Biol Phys 63 2005 214 223
10. D. Cardinale, M.T. Sandri, and A. Colombo Prognostic value of Troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy Circulation 109 2004 2749 2754
11. M.T. Sandri, D. Cardinale, and L. Zorzino Minor increases in plasma Troponin I predict decrease left ventricular ejection fraction after high-dose chemotherapy Clin Chem 49 2003 248 252
12. K. Jingu, K. Nemoto, and T. Kaneta Temporal change in brain natriuretic peptide after radiotherapy for thoracic esophageal cancer Int J Radiat Oncol Biol Phys 69 2007 1417 1423
13. P.J. Perik, E.G. De Vries, and F. Boomsma Use of natriuretic peptides for detecting cardiac dysfunction in long-term disease-free breast cancer survivors Anticancer Res 25 2005 3651 3657
14. J. Bryant, J. Picot, and L. Baxter Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: A systematic review Eur J Cancer 43 2007 1959 1966
15. International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon beam therapy. ICRU (1993) Report 50, 1 September. Bethesda, MD.
16. International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon beam therapy. ICRU Report 83, 2010. Bethesda, MD.
17. G. Gagliardi, L. Constine, and V. Moiseenko Radiation dose-volume effects in the heart Int J Radiat Oncol Biol Phys 76 2010 S77 S85
18. Pili G, Grimaldi L, Fidanza C, et al. A geometric and dosimetric approach to determine the probability of late cardiac mortality in left tangential breast irradiation. A comparison between wedged beams and field-in-field technique. Int J Radiat Oncol Biol Phys 2011 Feb. 9 [Epub ahead print] (in press).
19. F. Gustafsson, F. Steensgaard-Hansen, and J. Badskjaer Diagnostic and prognostic performance of N-terminal proBNP in primary care patients with suspected heart failure J Card Fail 11 5 Suppl 2005 S15 S20
20. A. Evangelista, F. Flachskampf, and P. Lancellotti European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies Eur J Echocardiogr 9 2008 438 448
21. L.F. Paszat, K.A. Vallis, and V.M. Benk A population-based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer Radiother Oncol 82 2007 294 300
22. J.J. Doyle, A.I. Neugut, and J.S. Jacobson Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients Int J Radiat Oncol Biol Phys 68 2007 82 93
23. S. Demirci, J. Nam, and J.L. Hubbs Radiation-induced cardiac toxicity after therapy for breast cancer: Interaction between treatment era and follow-up duration Int J Radiat Oncol Biol Phys 73 2009 980 987
24. G. Gagliardi, I. Lax, and L.E. Rutqvist Partial irradiation of the heart Semin Radiat Oncol 11 2001 224 233
25. J. Wondergerm, G.S. Erwin, and F. Marijke Circulating atrial natriuretic pepetide plasma levels as a marker for cardiac damage after radiotherapy Radiother Oncol 58 2001 295 301
26. M.R. Cowie, A.D. Struthers, and D.A. Wood Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care Lancet 350 1997 1349 1353
27. A.S. Maisel, P. Krishnaswamy, and R.M. mowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
28. L. Hughes-Davies, D. Sacks, and J. Rescigno Serum cardiac troponin T levels during treatment of early-stage breast cancer J Clin Oncol 13 1995 2582 2584
29. K.R. Kozak, T.S. Hong, and P.M. Sluss Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation Lung Cancer 62 2008 351 355
30. U. Nellessen, M. Zingel, and H. Hecker Effects of radiation therapy on myocardial cell integrity and pump function: Which role for cardiac biomarkers? Chemotherapy 56 2010 147 152